关于 "Aurora Kinase" 的结果37+ 个结果
- Aurora Kinases-IN-3CAS: 2840558-83-8
Aurora Kinases-IN-3(化合物15a)是一种口服活性AURKB抑制剂,通过破坏AURKB的有丝分裂定位来引发AURKB抑制活性。
- AKI603CAS: 1432515-73-5
AKI-603 is an inhibitor of Aurora kinase A (AurA), which is developed to overcome resistance mediated by BCR-ABL-T315I mutation.
- Casein Kinase inhibitor A51CAS: 2079068-74-7
Casein Kinase inhibitor A51 是一种有效且具有口服活性的酪蛋白激酶 1α (CK1α) 抑制剂。Casein Kinase inhibitor A51 可诱导白血病细胞凋亡 (apoptosis),并具有有效的抗白血病活性。
- Casein kinase 1δ-IN-3CAS: 349438-77-3
Casein kinase 1δ-IN-3 (Compound 23a) 是一种酪蛋白激酶 1δ (CK1d) 抑制剂,pIC50 为 6.5376 M。
- Casein kinase 1δ-IN-1CAS: 851871-94-8
Casein kinase 1δ-IN-1 (compound 822) 是酪蛋白激酶 1δ (CK1δ) 的抑制剂,抑制作用大于5%。Casein kinase 1δ-IN-1 可用于神经退行性疾病,如阿尔茨海默病的研究。
- Casein Kinase inhibitor A86CAS: 2079069-01-3
Casein Kinase inhibitor A86 是一种有效且具有口服活性的酪蛋白激酶 1α (CK1α) 抑制剂。Casein Kinase inhibitor A86 还抑制 CDK7 (TFIIH) 和 CDK9 (P-TEFb)。Casein Kinase inhibitor A86 可诱导白血病细胞凋亡 (apoptosis),并具有有效的抗白血病活性。
- CD532 hydrochloride
An inhibitor of Aurora A kinase activity and the Aurora A-N-Myc protein-protein interaction
- LY 294002 hydrochlorideCAS: 934389-88-5
Prototypical PI 3-kinase inhibitor; also inhibits other kinases
- ChiauranibCAS: 1256349-48-0
Chiauranib (CS2164) selectively inhibits multiple kinase targets aurora B kinase (AURKB), colony-stimulating factor 1 receptor (CSF1R), and vascular endothelial growth factor receptor (VEGFR)/platelet-derived growth factor receptor (PDGFR)/c-Kit , thereby inhibiting the rapid proliferation of tumor cells, enhancing the antitumor immunity, and inhibiting tumor angiogenesis, to achieve the anti-tumor efficacy.
- Aurkin ACAS: 1534060-58-6
Aurkin A是极光A激酶(Aurora A Kinase,也称Aurka)与TPX2相互作用的变抗抑制剂,通过靶向TPX2结合位点,Kd为3.77 μM。
- SNS-314CAS: 1057249-41-8
SNS-314 is a potent and selective inhibitor of Aurora A, Aurora B and Aurora C with IC50 of 9 nM, 31 nM, and 3 nM, respectively. It is less potent to Trk A/B, Flt4, Fms, Axl, c-Raf and DDR2. Phase 1.
- MAP2K1 Human
Mitogen-Activated Protein Kinase Kinase 1 Human Recombinant
- MAP2K2 Human
Mitogen-Activated Protein Kinase Kinase 2 Human Recombinant
- MAP2K3 Human
Mitogen-Activated Protein Kinase Kinase 3 Human Recombinant
- MAP2K6 Human
Mitogen-Activated Protein Kinase Kinase 6 Human Recombinant
- MAP2K6 Human, sf9
Mitogen-Activated Protein Kinase Kinase 6 Human Recombinant, sf9
- TAS-119CAS: 1453099-83-6
TAS-119 是一种有效的,选择性的,具有口服活性的 Aurora A 抑制剂,IC50 为 1.0 nM。TAS-119 对 Aurora A 的选择性高于其他蛋白激酶,包括 Aurora B (IC50 为 95 nM)。TAS-119 具有有效的抗肿瘤活性。
| 货号 | 产品名称 | CAS号 | 靶点 / 通路 | 引用 | 结构 |
|---|---|---|---|---|---|
| GC40667 | Aurora Kinase Inhibitor II | 331770-21-9 | Aurora Kinase | ||
Blocks Aurora A kinase activity | |||||
| GC73375 | Aurora Kinases-IN-3 | 2840558-83-8 | PLK | ||
Aurora Kinases-IN-3(化合物15a)是一种口服活性AURKB抑制剂,通过破坏AURKB的有丝分裂定位来引发AURKB抑制活性。 | |||||
| GC67899 | Aurora kinase inhibitor-8 | 2133001-88-2 | Aurora Kinase | ||
Aurora kinase inhibitor-8 是一种高选择性 Aurora 激酶的抑制剂。 | |||||
| GP22424 | AURKA Human | - | Aurora Kinase | ||
Aurora Kinase A Human Recombinant | |||||
| GP22425 | AURKB Human | - | Aurora Kinase | ||
Aurora Kinase B Human Recombinant | |||||
| GC62433 | AKI603 | 1432515-73-5 | Aurora Kinase | ||
AKI-603 is an inhibitor of Aurora kinase A (AurA), which is developed to overcome resistance mediated by BCR-ABL-T315I mutation. | |||||
| GC62442 | Casein Kinase inhibitor A51 | 2079068-74-7 | Apoptosis | ||
Casein Kinase inhibitor A51 是一种有效且具有口服活性的酪蛋白激酶 1α (CK1α) 抑制剂。Casein Kinase inhibitor A51 可诱导白血病细胞凋亡 (apoptosis),并具有有效的抗白血病活性。 | |||||
| GC67775 | Casein kinase 1δ-IN-3 | 349438-77-3 | Casein Kinase | ||
Casein kinase 1δ-IN-3 (Compound 23a) 是一种酪蛋白激酶 1δ (CK1d) 抑制剂,pIC50 为 6.5376 M。 | |||||
| GC66033 | Casein kinase 1δ-IN-1 | 851871-94-8 | Casein Kinase | ||
Casein kinase 1δ-IN-1 (compound 822) 是酪蛋白激酶 1δ (CK1δ) 的抑制剂,抑制作用大于5%。Casein kinase 1δ-IN-1 可用于神经退行性疾病,如阿尔茨海默病的研究。 | |||||
| GC63463 | Casein Kinase inhibitor A86 | 2079069-01-3 | Casein Kinase | ||
Casein Kinase inhibitor A86 是一种有效且具有口服活性的酪蛋白激酶 1α (CK1α) 抑制剂。Casein Kinase inhibitor A86 还抑制 CDK7 (TFIIH) 和 CDK9 (P-TEFb)。Casein Kinase inhibitor A86 可诱导白血病细胞凋亡 (apoptosis),并具有有效的抗白血病活性。 | |||||
| GC71277 | Casein kinase 1δ-IN-6 | 1579991-01-7 | Casein Kinase | ||
Casein kinase 1δ-IN-6是一种有效的选择性蛋白激酶CK-1δ抑制剂,IC50为23 nM。 | |||||
| GC72207 | Casein Kinase 2 Substrate Peptide | 132176-35-3 | Casein Kinase | ||
Casein Kinase 2 Substrate Peptide是一种常见的CK2底物肽。 | |||||
| GC62189 | CD532 hydrochloride | - | Aurora Kinase | ||
An inhibitor of Aurora A kinase activity and the Aurora A-N-Myc protein-protein interaction | |||||
| GC50009 | LY 294002 hydrochloride | 934389-88-5 | Autophagy | ||
Prototypical PI 3-kinase inhibitor; also inhibits other kinases | |||||
| GC62145 | Chiauranib | 1256349-48-0 | c-FMS | ||
Chiauranib (CS2164) selectively inhibits multiple kinase targets aurora B kinase (AURKB), colony-stimulating factor 1 receptor (CSF1R), and vascular endothelial growth factor receptor (VEGFR)/platelet-derived growth factor receptor (PDGFR)/c-Kit , thereby inhibiting the rapid proliferation of tumor cells, enhancing the antitumor immunity, and inhibiting tumor angiogenesis, to achieve the anti-tumor efficacy. | |||||
| GC72964 | Aurkin A | 1534060-58-6 | Aurora Kinase | ||
Aurkin A是极光A激酶(Aurora A Kinase,也称Aurka)与TPX2相互作用的变抗抑制剂,通过靶向TPX2结合位点,Kd为3.77 μM。 | |||||
| GC25940 | SNS-314 | 1057249-41-8 | Aurora Kinase | ||
SNS-314 is a potent and selective inhibitor of Aurora A, Aurora B and Aurora C with IC50 of 9 nM, 31 nM, and 3 nM, respectively. It is less potent to Trk A/B, Flt4, Fms, Axl, c-Raf and DDR2. Phase 1. | |||||
| GP22561 | MEK1 Human | - | Protein Kinases | ||
Mitogen Activated Kinase Kinase 1 Human Recombinant | |||||
| GP22543 | MAP2K1 Human | - | Mitogen-Activated Protein Kinase | ||
Mitogen-Activated Protein Kinase Kinase 1 Human Recombinant | |||||
| GP22544 | MAP2K2 Human | - | Mitogen-Activated Protein Kinase | ||
Mitogen-Activated Protein Kinase Kinase 2 Human Recombinant | |||||
| GP22545 | MAP2K3 Human | - | Mitogen-Activated Protein Kinase | ||
Mitogen-Activated Protein Kinase Kinase 3 Human Recombinant | |||||
| GP22546 | MAP2K6 Human | - | Mitogen-Activated Protein Kinase | ||
Mitogen-Activated Protein Kinase Kinase 6 Human Recombinant | |||||
| GP22547 | MAP2K6 Human, sf9 | - | Mitogen-Activated Protein Kinase | ||
Mitogen-Activated Protein Kinase Kinase 6 Human Recombinant, sf9 | |||||
| GC62482 | TAS-119 | 1453099-83-6 | Aurora Kinase | ||
TAS-119 是一种有效的,选择性的,具有口服活性的 Aurora A 抑制剂,IC50 为 1.0 nM。TAS-119 对 Aurora A 的选择性高于其他蛋白激酶,包括 Aurora B (IC50 为 95 nM)。TAS-119 具有有效的抗肿瘤活性。 | |||||
